BioLife Inventory vs Accounts Payable Analysis

BLFS Stock  USD 26.01  0.62  2.44%   
BioLife Solutions financial indicator trend analysis is way more than just evaluating BioLife Solutions prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioLife Solutions is a good investment. Please check the relationship between BioLife Solutions Inventory and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Inventory vs Accounts Payable

Inventory vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioLife Solutions Inventory account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.
The correlation between BioLife Solutions' Inventory and Accounts Payable is 0.8. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of BioLife Solutions, assuming nothing else is changed. The correlation between historical values of BioLife Solutions' Inventory and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of BioLife Solutions are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Inventory i.e., BioLife Solutions' Inventory and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.8
Relationship DirectionPositive 
Relationship StrengthStrong

Inventory

Accounts Payable

An accounting item on the balance sheet that represents BioLife Solutions obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BioLife Solutions are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from BioLife Solutions' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 753.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 52.9 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses68.1M93.7M117.6M123.5M
Cost Of Revenue81.4M107.9M96.5M101.3M

BioLife Solutions fundamental ratios Correlations

1.00.980.590.99-0.15-0.790.680.990.990.970.850.95-0.050.980.960.990.960.930.890.930.940.280.180.610.79
1.00.980.620.99-0.16-0.780.690.990.980.970.850.95-0.070.970.960.980.960.920.890.930.930.270.180.590.79
0.980.980.520.990.02-0.880.570.970.970.990.790.96-0.080.990.991.00.940.90.930.980.950.310.190.70.87
0.590.620.520.51-0.46-0.380.680.610.550.580.520.55-0.030.570.460.510.530.340.370.550.30.10.1-0.190.52
0.990.990.990.51-0.09-0.830.650.980.990.970.850.96-0.090.980.981.00.970.930.920.940.960.30.190.690.81
-0.15-0.160.02-0.46-0.09-0.23-0.8-0.1-0.10.02-0.54-0.11-0.29-0.040.09-0.02-0.27-0.040.170.090.060.10.130.30.28
-0.79-0.78-0.88-0.38-0.83-0.23-0.35-0.76-0.8-0.87-0.61-0.9-0.01-0.9-0.87-0.86-0.8-0.64-0.81-0.95-0.79-0.33-0.15-0.75-0.93
0.680.690.570.680.65-0.8-0.350.630.640.570.920.650.140.610.520.60.780.530.450.50.50.10.080.160.32
0.990.990.970.610.98-0.1-0.760.630.980.970.80.93-0.080.960.950.980.930.940.890.920.930.270.180.570.79
0.990.980.970.550.99-0.1-0.80.640.980.950.820.95-0.070.970.950.980.950.930.880.940.950.250.190.650.77
0.970.970.990.580.970.02-0.870.570.970.950.770.94-0.110.980.980.980.920.870.920.970.920.320.20.630.9
0.850.850.790.520.85-0.54-0.610.920.80.820.770.840.110.810.760.820.950.750.690.720.770.20.120.530.53
0.950.950.960.550.96-0.11-0.90.650.930.950.940.840.090.980.920.960.960.840.820.960.90.290.080.690.83
-0.05-0.07-0.08-0.03-0.09-0.29-0.010.14-0.08-0.07-0.110.110.09-0.02-0.16-0.090.04-0.06-0.26-0.04-0.030.03-0.310.12-0.18
0.980.970.990.570.98-0.04-0.90.610.960.970.980.810.98-0.020.970.990.950.870.890.980.930.310.160.680.88
0.960.960.990.460.980.09-0.870.520.950.950.980.760.92-0.160.970.980.920.90.980.950.950.30.280.710.88
0.990.981.00.511.0-0.02-0.860.60.980.980.980.820.96-0.090.990.980.960.920.930.960.960.310.190.710.85
0.960.960.940.530.97-0.27-0.80.780.930.950.920.950.960.040.950.920.960.860.850.90.910.270.160.670.74
0.930.920.90.340.93-0.04-0.640.530.940.930.870.750.84-0.060.870.90.920.860.860.80.960.240.140.670.63
0.890.890.930.370.920.17-0.810.450.890.880.920.690.82-0.260.890.980.930.850.860.880.90.260.370.680.85
0.930.930.980.550.940.09-0.950.50.920.940.970.720.96-0.040.980.950.960.90.80.880.890.310.180.690.92
0.940.930.950.30.960.06-0.790.50.930.950.920.770.9-0.030.930.950.960.910.960.90.890.280.150.80.73
0.280.270.310.10.30.1-0.330.10.270.250.320.20.290.030.310.30.310.270.240.260.310.28-0.080.390.4
0.180.180.190.10.190.13-0.150.080.180.190.20.120.08-0.310.160.280.190.160.140.370.180.15-0.080.060.23
0.610.590.7-0.190.690.3-0.750.160.570.650.630.530.690.120.680.710.710.670.670.680.690.80.390.060.58
0.790.790.870.520.810.28-0.930.320.790.770.90.530.83-0.180.880.880.850.740.630.850.920.730.40.230.58
Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

BioLife Solutions fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets93.0M234.8M552.6M450.2M412.7M433.3M
Other Current Liab3.5M9.1M20.2M15.7M15.4M16.2M
Total Current Liabilities7.8M15.6M40.0M44.6M42.2M44.3M
Total Stockholder Equity83.0M205.2M480.8M(246.9M)337.7M354.5M
Property Plant And Equipment Net6.6M19.8M36.8M39.2M32.6M34.2M
Net Debt(5.1M)(79.3M)(43.0M)24.3M7.3M7.6M
Retained Earnings(100.1M)(97.4M)(105.0M)(246.9M)(313.3M)(297.7M)
Cash6.4M90.5M69.9M19.4M35.4M37.2M
Non Current Assets Total68.8M120.1M426.7M311.8M292.1M306.7M
Non Currrent Assets Other3.9M4.7M9.8M9.3M8.0M8.4M
Other Assets50K120.1M426.7M386.2M444.1M466.3M
Cash And Short Term Investments6.4M90.5M69.9M64.1M51.7M54.3M
Common Stock Shares Outstanding19.5M27.3M38.5M42.5M43.7M45.9M
Liabilities And Stockholders Equity93.0M234.8M552.6M(160.9M)412.7M433.3M
Other Current Assets13.1M4.7M4.7M6.9M6.8M3.6M
Other Stockholder Equity183.1M302.6M585.4M611.7M651.3M683.9M
Total Liab10.0M29.6M71.9M86.0M75.1M78.8M
Property Plant And Equipment Gross6.6M19.8M43.5M48.4M42.1M44.2M
Total Current Assets24.2M114.7M125.9M138.5M120.6M126.6M
Accounts Payable3.1M3.7M14.9M15.4M6.9M7.3M
Non Current Liabilities Total2.2M14.0M31.9M41.5M32.9M34.5M
Inventory11.1M11.6M28.3M34.9M43.5M45.6M
Net Receivables5.3M8.0M23.2M33.9M18.7M19.6M
Common Stock Total Equity14.0K19K21K33K38.0K35.1K
Common Stock21K33K42K43K45K36.6K
Property Plant Equipment1.3M5.6M24.5M46.6M53.6M56.3M
Other Liab41.1M14.0M31.9M2.6M3.0M2.8M
Net Tangible Assets(12.2M)205.2M480.8M364.2M418.8M439.8M
Retained Earnings Total Equity(74.0M)(71.0M)(100.1M)(97.4M)(87.6M)(92.0M)
Capital Surpluse84.0M114.2M143.5M302.6M348.0M365.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.